Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for insulin sensitivity in adults with type 1 diabetes
NL-OMON34115Phase 2Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anakinra in diabetes mellitus type 1 (T1D), sponsored by Radboud University Medical Center. Primary endpoint: Insulin sensitivity. Started Mar 2011; status: active, not recruiting.
02
Drugs
anakinra
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON34115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34115.